OS Therapies Incorporated (OSTX) vs Telomir Pharmaceuticals, Inc. (TELO)

OS Therapies Incorporated and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. OS Therapies Incorporated and Telomir Pharmaceuticals, Inc. are of similar size ($83.2M and $77.7M). Across the 8 metrics below, OS Therapies Incorporated leads on 5 and Telomir Pharmaceuticals, Inc. on 3.

Valuation

Metric OSTX TELO Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 14.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (65.66%) (74.59%) (28.84%)
Free cash flow yield (25.43%) (6.62%) (23.03%)

Profitability

Metric OSTX TELO Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,129.52% (1,885.50%) (57.72%)
Return on assets (389.65%) (1,678.31%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OSTX TELO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 23.32% 41.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric OSTX TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 0.18 16.14 4.73
Net debt to EBITDA 0.01 0.69 0.96

Dividend

Metric OSTX TELO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric OSTX TELO Biotechnology median
Market cap 77.70m 83.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack